When the ‘tobacco’ is in the pot

The tobacco plant is the world’s most widely used crop, with tobacco as its primary crop.

It grows in many parts of the world, and is an important crop in many of the countries that produce it.

It’s also one of the most toxic, with nearly two million people dying every year from its use.

The plant is not only one of most toxic crops in the world but also one that is used in the most widely-used and least effective ways in the developing world.

But is there really a tobacco plant in the cannabis plant?

A team of scientists has spent the past few years investigating the plant and its chemical makeup.

It turns out that the plant is quite a bit like tobacco, with many of its characteristics, including the presence of tetrahydrocannabinol (THC), the psychoactive chemical in marijuana.

That makes the tobacco plant a valuable target for medicinal cannabis researchers.

“It’s really a fascinating case, because the plants have similar chemical compositions to cannabis,” says study author Daniel Mascarenhas, a researcher in the School of Biological Sciences at the University of California, Berkeley.

“In the past, we thought that tobacco plants were quite innocuous, but now we’re finding out that they are quite toxic.”

The team has found that the tobacco-like properties of cannabis are due to tetrahylamines.

They found that tetrahyl tetrahymethanol (THEA) is present in the tobacco.

The compound has a much higher affinity for the human brain than THC, and when injected into rats, it caused severe brain damage, including seizures and death.

This is what the cannabis researchers are looking for in their study.

“We have a pretty clear view of what’s going on with these compounds, and what they’re doing to the brain,” says Mascares.

“The fact that they’re being found in cannabis and that they act like THC, that really tells us something about what’s happening in the brain.”

A common theme among the studies that the researchers conducted was the lack of a clear mechanism for THC to affect the brain, despite the fact that tetahydrocannabis is found in marijuana plants.

“When we looked at all the plants that we looked through, they had very little THC,” says Dr. John L. Wier, a professor of medicine and of pathology at the Baylor College of Medicine.

“They’re almost all non-psychoactive and have very little effect on the brain.

The only thing that they did are give them to the rats and the rats ate the stuff.”

But the scientists did find that a different type of tetahylamine, called anandamide, was also found in the plants.

That’s when the researchers noticed that the tetrahysin-anandamide system could have something to do with THC.

Anandamide is a type of anandine in marijuana that is known to act as a vasoconstrictor.

That means it keeps the blood vessels in the arteries open, making them easier to dilate and reduce the pressure.

It also has a lower affinity for receptors in the human body than THC.

The team also found that in animals that were injected with THC, they showed more inflammation than in animals not given THC.

This inflammation may be why it has such a high affinity for human brain receptors.

So what can we do about this?

“I think what we’re seeing is the end result of these endocannabinoids that are acting on the human nervous system,” says Landon Rauch, a molecular biologist at the Medical University of South Carolina.

“These endocannoids are acting in a way that the human neural system is trying to control, which is to slow down the progression of diseases and slow down inflammation.”

That could mean we need to take the endocancannabinoid system out of cannabis.

But in order to do that, the researchers are also trying to understand what happens to the human endocanabia in the body.

It could also mean that there is a mechanism that works in the endocrine system and we can use that to treat cancer.

So the researchers hope that they’ll be able to find the answers to those questions.

And they are hopeful that this study will be the beginning of a new era for medicinal marijuana research.

“I hope this will be a step forward and a new avenue for scientific research in this area,” says Wier.

“That will allow us to learn about how the endocranial system controls inflammation, how the human neurochemistry regulates inflammation, and how it affects disease.”

This story is part of CBC’s series Cannabis in the 21st Century.